CompuGroup Historical Balance Sheet

0MSD Stock

14.81 0.56 3.93%

Trend analysis of CompuGroup Medical AG balance sheet accounts such as Other Current Liab of 177.9 M, Total Current Liabilities of 220.4 M or Total Stockholder Equity of 701.1 M provides information on CompuGroup Medical's total assets, liabilities, and equity, which is the actual value of CompuGroup Medical to its prevalent stockholders. By breaking down trends over time using CompuGroup Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining CompuGroup Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CompuGroup Medical is a good buy for the upcoming year.

CompuGroup Medical Inventory

11.48 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About CompuGroup Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of CompuGroup Medical at a specified time, usually calculated after every quarter, six months, or one year. CompuGroup Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CompuGroup Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CompuGroup currently owns. An asset can also be divided into two categories, current and non-current.

CompuGroup Medical Balance Sheet Chart

At this time, CompuGroup Medical's Other Current Liabilities is comparatively stable compared to the past year. Total Stockholder Equity is likely to gain to about 701.1 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 220.4 M in 2024.

Total Assets Total Current Liabilities Total Stockholder Equity Property Plant And Equipment Net Accumulated Other Comprehensive Income Net Tangible Assets

Total Assets

Total assets refers to the total amount of CompuGroup Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CompuGroup Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on CompuGroup Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CompuGroup Medical AG are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Accumulated Other Comprehensive Income

Gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Most accounts from CompuGroup Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into CompuGroup Medical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Total Stockholder Equity	612.1M	672.4M	667.7M	701.1M
Total Current Liabilities	398.3M	375.5M	346.8M	220.4M

Total Stockholder Equity Total Current Liabilities

CompuGroup Medical balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Other Assets	Short Term Debt	Short Long Term Debt Total	Current Deferred Revenue	Short Term Investments	Non Current Liabilities Total
Total Assets		0.59	0.97	0.88	0.97	0.96	0.86	0.93	1.0	0.73	0.93	0.66	0.72	0.79	0.51	0.07	0.99	0.99	0.6	0.97	0.35	0.57	0.98	0.62	-0.23	0.98
Other Current Liab	0.59		0.6	0.79	0.57	0.61	0.85	0.43	0.6	0.42	0.43	0.5	0.83	0.37	0.18	-0.16	0.59	0.55	0.93	0.51	0.35	0.22	0.61	0.84	-0.23	0.65
Total Current Liabilities	0.97	0.6		0.85	0.96	0.97	0.85	0.93	0.97	0.64	0.93	0.69	0.76	0.76	0.42	0.01	0.98	0.96	0.62	0.94	0.44	0.71	0.97	0.64	-0.16	0.97
Total Stockholder Equity	0.88	0.79	0.85		0.83	0.8	0.99	0.85	0.88	0.65	0.84	0.49	0.9	0.66	0.52	0.12	0.85	0.87	0.67	0.85	0.22	0.5	0.86	0.77	-0.31	0.85
Property Plant And Equipment Net	0.97	0.57	0.96	0.83		0.96	0.83	0.89	0.97	0.67	0.89	0.66	0.68	0.87	0.48	0.05	0.97	0.97	0.61	0.94	0.39	0.59	0.97	0.62	-0.2	0.97
Net Debt	0.96	0.61	0.97	0.8	0.96		0.8	0.86	0.96	0.64	0.86	0.76	0.69	0.78	0.39	-0.06	0.98	0.96	0.68	0.92	0.45	0.57	0.98	0.62	-0.16	0.99
Retained Earnings	0.86	0.85	0.85	0.99	0.83	0.8		0.81	0.87	0.61	0.81	0.49	0.93	0.64	0.47	0.08	0.84	0.84	0.74	0.81	0.29	0.51	0.85	0.83	-0.28	0.85
Cash	0.93	0.43	0.93	0.85	0.89	0.86	0.81		0.93	0.68	1.0	0.54	0.68	0.73	0.5	0.09	0.92	0.93	0.38	0.94	0.3	0.75	0.92	0.56	-0.25	0.89
Non Current Assets Total	1.0	0.6	0.97	0.88	0.97	0.96	0.87	0.93		0.73	0.93	0.65	0.72	0.77	0.51	0.08	0.99	0.99	0.61	0.96	0.35	0.56	0.98	0.63	-0.22	0.98
Non Currrent Assets Other	0.73	0.42	0.64	0.65	0.67	0.64	0.61	0.68	0.73		0.68	0.56	0.36	0.62	0.24	-0.08	0.71	0.72	0.31	0.76	0.28	0.2	0.71	0.23	-0.09	0.7
Cash And Short Term Investments	0.93	0.43	0.93	0.84	0.89	0.86	0.81	1.0	0.93	0.68		0.53	0.68	0.73	0.49	0.1	0.92	0.93	0.38	0.93	0.31	0.75	0.92	0.56	-0.22	0.89
Net Receivables	0.66	0.5	0.69	0.49	0.66	0.76	0.49	0.54	0.65	0.56	0.53		0.34	0.59	-0.11	-0.63	0.73	0.7	0.54	0.72	0.57	0.32	0.74	0.34	-0.31	0.74
Common Stock Shares Outstanding	0.72	0.83	0.76	0.9	0.68	0.69	0.93	0.68	0.72	0.36	0.68	0.34		0.47	0.44	0.16	0.69	0.69	0.75	0.65	0.25	0.54	0.69	0.81	-0.15	0.72
Inventory	0.79	0.37	0.76	0.66	0.87	0.78	0.64	0.73	0.77	0.62	0.73	0.59	0.47		0.32	-0.04	0.81	0.84	0.34	0.84	0.41	0.42	0.8	0.34	-0.29	0.8
Other Current Assets	0.51	0.18	0.42	0.52	0.48	0.39	0.47	0.5	0.51	0.24	0.49	-0.11	0.44	0.32		0.67	0.44	0.49	0.16	0.43	-0.41	0.28	0.43	0.35	-0.13	0.43
Other Stockholder Equity	0.07	-0.16	0.01	0.12	0.05	-0.06	0.08	0.09	0.08	-0.08	0.1	-0.63	0.16	-0.04	0.67		-0.02	0.03	-0.14	-0.04	-0.49	0.04	-0.06	0.07	0.36	-0.04
Total Liab	0.99	0.59	0.98	0.85	0.97	0.98	0.84	0.92	0.99	0.71	0.92	0.73	0.69	0.81	0.44	-0.02		0.99	0.62	0.96	0.42	0.59	1.0	0.61	-0.22	0.99
Total Current Assets	0.99	0.55	0.96	0.87	0.97	0.96	0.84	0.93	0.99	0.72	0.93	0.7	0.69	0.84	0.49	0.03	0.99		0.56	0.98	0.34	0.56	0.98	0.57	-0.27	0.98
Common Stock	0.6	0.93	0.62	0.67	0.61	0.68	0.74	0.38	0.61	0.31	0.38	0.54	0.75	0.34	0.16	-0.14	0.62	0.56		0.47	0.38	0.2	0.62	0.8	-0.11	0.67
Accounts Payable	0.97	0.51	0.94	0.85	0.94	0.92	0.81	0.94	0.96	0.76	0.93	0.72	0.65	0.84	0.43	-0.04	0.96	0.98	0.47		0.32	0.57	0.96	0.5	-0.33	0.95
Other Assets	0.35	0.35	0.44	0.22	0.39	0.45	0.29	0.3	0.35	0.28	0.31	0.57	0.25	0.41	-0.41	-0.49	0.42	0.34	0.38	0.32		0.3	0.41	0.24	0.1	0.42
Short Term Debt	0.57	0.22	0.71	0.5	0.59	0.57	0.51	0.75	0.56	0.2	0.75	0.32	0.54	0.42	0.28	0.04	0.59	0.56	0.2	0.57	0.3		0.59	0.51	-0.02	0.55
Short Long Term Debt Total	0.98	0.61	0.97	0.86	0.97	0.98	0.85	0.92	0.98	0.71	0.92	0.74	0.69	0.8	0.43	-0.06	1.0	0.98	0.62	0.96	0.41	0.59		0.64	-0.24	0.99
Current Deferred Revenue	0.62	0.84	0.64	0.77	0.62	0.62	0.83	0.56	0.63	0.23	0.56	0.34	0.81	0.34	0.35	0.07	0.61	0.57	0.8	0.5	0.24	0.51	0.64		-0.18	0.64
Short Term Investments	-0.23	-0.23	-0.16	-0.31	-0.2	-0.16	-0.28	-0.25	-0.22	-0.09	-0.22	-0.31	-0.15	-0.29	-0.13	0.36	-0.22	-0.27	-0.11	-0.33	0.1	-0.02	-0.24	-0.18		-0.22
Non Current Liabilities Total	0.98	0.65	0.97	0.85	0.97	0.99	0.85	0.89	0.98	0.7	0.89	0.74	0.72	0.8	0.43	-0.04	0.99	0.98	0.67	0.95	0.42	0.55	0.99	0.64	-0.22

Click cells to compare fundamentals

CompuGroup Medical Account Relationship Matchups

CompuGroup Medical balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.1B	1.6B	1.8B	1.9B	1.9B	988.6M
Other Current Liab	61.2M	71.5M	73.5M	89.6M	169.4M	177.9M
Total Current Liabilities	236.3M	290.5M	398.3M	375.5M	346.8M	220.4M
Total Stockholder Equity	259.1M	638.7M	612.1M	672.4M	667.7M	701.1M
Property Plant And Equipment Net	131.3M	136.3M	158M	160.9M	165.7M	86.1M
Net Debt	467.0M	479.9M	634.0M	696.0M	702.5M	355.9M
Retained Earnings	221.5M	273.1M	310.7M	611.3M	702.9M	738.1M
Cash	43.8M	74.6M	107.3M	90.5M	64.5M	42.4M
Non Current Assets Total	832.9M	1.3B	1.4B	1.5B	1.5B	787.0M
Non Currrent Assets Other	24.5M	25.3M	27.4M	56.3M	41.6M	22.5M
Cash And Short Term Investments	44.7M	75.6M	107.6M	91.0M	64.5M	43.1M
Net Receivables	119.9M	(1K)	182.6M	221.9M	211.1M	107.0M
Common Stock Shares Outstanding	49.4M	53.7M	53.0M	52.3M	52.5M	55.5M
Liabilities And Stockholders Equity	1.1B	1.6B	1.8B	1.9B	1.9B	988.6M
Inventory	27.5M	18.2M	20.6M	29.4M	18.9M	11.5M
Other Current Assets	39.1M	214.3M	60.0M	78.9M	75.3M	46.9M
Other Stockholder Equity	(86.3M)	531.2M	(98.8M)	(105.2M)	(94.7M)	(90.0M)
Total Liab	805.9M	926.8M	1.2B	1.3B	1.2B	665.6M
Total Current Assets	232.9M	308.1M	370.8M	420.8M	369.8M	201.6M
Accounts Payable	47.1M	64.5M	93.2M	110.6M	82.3M	44.0M
Short Term Debt	57.9M	56.3M	115.7M	53.3M	25.9M	49.4M
Short Long Term Debt Total	510.8M	554.5M	741.3M	786.5M	766.9M	448.1M
Current Deferred Revenue	118.0M	154.1M	177.6M	69.0M	220.1M	231.1M
Short Term Investments	944K	1.0M	340K	551K	146K	138.7K
Non Current Liabilities Total	569.6M	636.3M	780.2M	895.1M	883.8M	498.0M
Intangible Assets	337.4M	545.7M	625.9M	654.7M	625.8M	419.2M
Accumulated Other Comprehensive Income	(33.1M)	53.7M	(45.1M)	(51.5M)	719.1M	755.1M
Good Will	330.9M	542.4M	588.4M	639.2M	684.1M	414.6M
Long Term Debt	318.1M	302.6M	424.5M	470.2M	540.7M	402.9M
Property Plant Equipment	131.3M	136.3M	158M	160.9M	185.0M	129.9M
Other Liab	116.7M	138.1M	154.6M	162.0M	186.3M	134.3M
Net Tangible Assets	(407.9M)	(447.1M)	(599.3M)	(618.4M)	(556.6M)	(584.4M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for CompuGroup Stock Analysis

When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC